However, the expression levels of MELK, PTPRZ1, and NOVA1, along with TMEM97, have been significantly upregulated in temozolomide-resistant GBM cell lines compared to normal astrocyte cells (Fig. 4I–O). The gene discussed is PTPRZ1; the disease is glioblastoma.